Citadel Advisors
ASXC

Citadel Advisors’s Asensus Surgical, Inc. ASXC Stock Holding History

Citadel Advisors’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,400
Closed -$1.01K – 15709
2024
Q1 		$1.01K Sell
4,400
-60,800
-93% -$17.7K ﹤0.01% 14205
2023
Q4 		$20.8K Sell
65,200
-18,900
-22% -$4.87K ﹤0.01% 12588
2023
Q3 		$22.7K Sell
84,100
-6,100
-7% -$2.22K ﹤0.01% 12522
2023
Q2 		$45.6K Buy
90,200
+16,500
+22% +$9.86K ﹤0.01% 11912
2023
Q1 		$48.5K Sell
73,700
-66,100
-47% -$44.8K ﹤0.01% 12189
2022
Q4 		$48.5K Buy
139,800
+22,000
+19% +$8.94K ﹤0.01% 12180
2022
Q3 		$53K Buy
117,800
+13,600
+13% +$7.09K ﹤0.01% 11587
2022
Q2 		$41K Sell
104,200
-2,600
-2% -$1.16K ﹤0.01% 12056
2022
Q1 		$67K Buy
106,800
+100
+0.1% +$77 ﹤0.01% 12608
2021
Q4 		$118K Sell
106,700
-15,200
-12% -$23.5K ﹤0.01% 12546
2021
Q3 		$226K Sell
121,900
-199,600
-62% -$448K ﹤0.01% 11717
2021
Q2 		$1.02M Sell
321,500
-16,700
-5% -$41.7K ﹤0.01% 8323
2021
Q1 		$1.1M Buy
338,200
+290,508
+609% +$1.05M ﹤0.01% 7882
2020
Q4 		$30K Buy
47,692
+23,992
+101% +$11K ﹤0.01% 10710
2020
Q3 		$8K Sell
23,700
-29,500
-55% -$11.4K ﹤0.01% 9948
2020
Q2 		$29K Buy
53,200
+26,300
+98% +$12.7K ﹤0.01% 9470
2020
Q1 		$9K Buy
+26,900
New +$28.1K ﹤0.01% 9440
2019
Q4 		– Sell
-9,023
Closed -$73K – 9909
2019
Q3 		$73K Sell
9,023
-2,392
-21% -$32.5K ﹤0.01% 8606
2019
Q2 		$202K Sell
11,415
-1,847
-14% -$40.4K ﹤0.01% 8178
2019
Q1 		$410K Buy
13,262
+2,508
+23% +$84.1K ﹤0.01% 7120
2018
Q4 		$316K Buy
10,754
+3,577
+50% +$163K ﹤0.01% 7171
2018
Q3 		$541K Sell
7,177
-9,661
-57% -$654K ﹤0.01% 6574
2018
Q2 		$954K Buy
16,838
+11,207
+199% +$408K ﹤0.01% 5302
2018
Q1 		$124K Buy
5,631
+3,800
+208% +$86.9K ﹤0.01% 7635
2017
Q4 		$46K Sell
1,831
-4,269
-70% -$131K ﹤0.01% 7653
2017
Q3 		$113K Buy
+6,100
New +$71K ﹤0.01% 6991
2016
Q4 		– Sell
-3,269
Closed -$72K – 7978
2016
Q3 		$72K Sell
3,269
-2,654
-45% -$48.5K ﹤0.01% 6760
2016
Q2 		$94K Sell
5,923
-7,639
-56% -$240K ﹤0.01% 6216
2016
Q1 		$749K Buy
+13,562
New +$581K ﹤0.01% 3837
2015
Q4 		– Sell
-292
Closed -$9K – 9309
2015
Q3 		$9K Buy
+292
New +$10.8K ﹤0.01% 8508

Other funds holding ASXC

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CM
Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citadel Advisors's ASXC Position: Q2 2024 in Review

Citadel Advisors sold out of Asensus Surgical, Inc. (ASXC) in Q2 2024, closing a stake of 26,106 shares — an estimated $6K sold.

Citadel Advisors first reported a position in ASXC in Q2 2015 and held it in 21 quarters. The position peaked at $8.15M in Q1 2021. 64 funds tracked by Wall St. Rank hold ASXC as of Q2 2024.

  • Citadel Advisors reported no remaining Asensus Surgical, Inc. position as of Q2 2024 after selling out during the quarter.
  • Citadel Advisors sold 26,106 Asensus Surgical, Inc. shares in Q2 2024, an estimated $6K.
  • Citadel Advisors first reported a position in Asensus Surgical, Inc. in Q2 2015 and held it in 21 quarters.
  • Citadel Advisors's Asensus Surgical, Inc. position peaked at $8.15M in Q1 2021.
  • 64 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.